Compare OFG & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OFG | RXRX |
|---|---|---|
| Founded | 1964 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | N/A | 2021 |
| Metric | OFG | RXRX |
|---|---|---|
| Price | $41.76 | $4.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $45.75 | $8.00 |
| AVG Volume (30 Days) | 245.0K | ★ 22.7M |
| Earning Date | 01-22-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.87% | N/A |
| EPS Growth | ★ 6.55 | N/A |
| EPS | ★ 4.40 | N/A |
| Revenue | ★ $624,004,000.00 | $43,689,000.00 |
| Revenue This Year | N/A | $6.74 |
| Revenue Next Year | $1.02 | $34.31 |
| P/E Ratio | $9.49 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $33.15 | $3.79 |
| 52 Week High | $46.11 | $12.36 |
| Indicator | OFG | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 53.76 | 43.62 |
| Support Level | $41.75 | $4.18 |
| Resistance Level | $43.19 | $4.43 |
| Average True Range (ATR) | 0.77 | 0.28 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 46.67 | 14.21 |
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.